Expanding Access to Quality Medicines
Crescent Pharmaceutical Group works with licensed pharmaceutical distributors, importers, wholesalers and healthcare organisations seeking to introduce high-quality generic medicines into international markets. Through our established UK portfolio, global in-house development and manufacturing capabilities, UK manufacturing operations and carefully managed network of contract development and manufacturing partners, we can support a range of international supply and market-entry opportunities.
Partnering with Crescent
Why Work with Crescent?
We develop long-term international partnerships built around product suitability, regulatory requirements, dependable supply and a clear understanding of each local market. Our International Business Development and Regulatory Affairs teams work with prospective partners to assess available products, registration pathways, forecast demand and the most appropriate commercial model.
Crescent currently supplies a growing range of pharmaceutical products internationally and continues to expand its presence in markets where UK approvals, regulatory documentation and established pharmaceutical supply capabilities can provide a strong foundation for market entry.
Extensive Product Portfolio
Access opportunities across Crescent’s broad and expanding portfolio of generic medicines, covering multiple dosage forms and therapeutic areas.
Development and Manufacturing Capability
Benefit from a combination of UK manufacturing, global in-house development, global manufacturing and qualified contract development and manufacturing partners.
Regulatory Expertise
Work with experienced Regulatory Affairs teams supporting product assessment, registration planning, dossier management and ongoing product lifecycle requirements.
Dependable Pharmaceutical Supply
Our approach combines quality oversight, established supply-chain relationships, inventory planning and licensed pharmaceutical distribution to support continuity of supply.
International Partnership Models
Crescent considers different partnership structures according to the product, territory, regulatory pathway and commercial opportunity.
These may include:
Finished Product Supply
Supply of approved or commercially available pharmaceutical products for distribution within agreed international territories.
Product Registration and Market Entry
Collaboration with local partners to assess registration requirements and introduce appropriate products into new markets.
Portfolio Partnerships
A structured partnership covering a selected basket of products rather than a single-product opportunity, supporting broader and more sustainable market development.
Licensing and Strategic Collaboration
Territory-specific licensing, development or commercial arrangements where supported by the product rights, regulatory position and long-term strategic fit.
All opportunities remain subject to regulatory assessment, product availability, territorial rights, commercial review and completion of Crescent’s customer qualification process.
Supporting International Market Development
Our international model is supported by capabilities across the wider Crescent Pharmaceutical Group.
These include:
- An extensive UK generic medicines portfolio
- Global in-house pharmaceutical development
- UK and international manufacturing capability
- Strategic contract manufacturing and development partners
- Regulatory Affairs and product lifecycle support
- Quality Assurance and supplier oversight
- Licensed pharmaceutical warehousing and distribution
- Supply-chain and inventory planning
Who We Work With
We welcome enquiries from appropriately licensed organisations, including:
- Pharmaceutical distributors
- Importers and wholesalers
- Government and institutional procurement organisations
- Hospital and healthcare supply organisations
- Established pharmaceutical companies
- Regional commercial and licensing partners
Prospective partners must hold the licences and regulatory approvals required for the proposed activities within their territory. This combined model enables Crescent to consider opportunities across different markets, dosage forms and regulatory pathways while maintaining appropriate quality and commercial governance.
How We Assess New Opportunities
To determine whether an opportunity is suitable, our teams review:
Company and Regulatory Status
Your organisation’s pharmaceutical licences, regulatory standing, operating history and existing market presence.
Territory
The country or region in which you are seeking distribution, registration or commercial rights.
Product Requirements
The products, dosage forms or therapeutic areas of interest and any relevant local product specifications.
Registration Pathway
Local dossier, approval, labelling, pharmacovigilance, importation and market-access requirements.
Commercial Potential
Forecast annual demand, expected launch timing, target customers and route to market.
Strategic Fit
The suitability of the opportunity for Crescent’s portfolio, available rights, supply model and long-term international strategy. Providing complete and accurate information will enable our teams to assess your enquiry more efficiently.
Become an International Partner
Please complete the enquiry form below to introduce your organisation and proposed opportunity. A member of our International Business Development team will review the information provided and contact you where there is a potential fit with Crescent’s portfolio and international strategy.
Submission of an enquiry does not create an appointment, exclusivity arrangement, supply commitment or distribution agreement.